Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy

Modulating effector immune cells via monoclonal antibodies (mAbs) and facilitating the co-engagement of T cells and tumor cells via chimeric antigen receptor- T cells or bispecific T cell-engaging antibodies are two typical cancer immunotherapy approaches. We speculated that immobilizing two types o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Cheng-Tao, Chen, Kai-Ge, Liu, An, Huang, Hua, Fan, Ya-Nan, Zhao, Dong-Kun, Ye, Qian-Ni, Zhang, Hou-Bing, Xu, Cong-Fei, Shen, Song, Xiong, Meng-Hua, Du, Jin-Zhi, Yang, Xian-Zhu, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921676/
https://www.ncbi.nlm.nih.gov/pubmed/33649336
http://dx.doi.org/10.1038/s41467-021-21497-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921676/
https://www.ncbi.nlm.nih.gov/pubmed/33649336
http://dx.doi.org/10.1038/s41467-021-21497-6

Ejemplares similares